144 related articles for article (PubMed ID: 28557170)
1. Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney.
Demir Y; Işık M; Gülçin İ; Beydemir Ş
J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28557170
[TBL] [Abstract][Full Text] [Related]
2. Antidiabetic properties of dietary phenolic compounds: Inhibition effects on α-amylase, aldose reductase, and α-glycosidase.
Demir Y; Durmaz L; Taslimi P; Gulçin İ
Biotechnol Appl Biochem; 2019 Sep; 66(5):781-786. PubMed ID: 31135076
[TBL] [Abstract][Full Text] [Related]
3. Inhibition effects of quinones on aldose reductase: Antidiabetic properties.
Demir Y; Özaslan MS; Duran HE; Küfrevioğlu Öİ; Beydemir Ş
Environ Toxicol Pharmacol; 2019 Aug; 70():103195. PubMed ID: 31125830
[TBL] [Abstract][Full Text] [Related]
4. The interactions of cephalosporins on polyol pathway enzymes from sheep kidney.
Şengül B; Beydemir Ş
Arch Physiol Biochem; 2018 Feb; 124(1):35-44. PubMed ID: 28758816
[TBL] [Abstract][Full Text] [Related]
5. Anti-diabetic Properties of Calcium Channel Blockers: Inhibition Effects on Aldose Reductase Enzyme Activity.
Türkeş C; Demir Y; Beydemir Ş
Appl Biochem Biotechnol; 2019 Sep; 189(1):318-329. PubMed ID: 30980289
[TBL] [Abstract][Full Text] [Related]
6. In vitro aldose reductase inhibitory activity of some flavonyl-2,4-thiazolidinediones.
Daş-Evcimen N; Bozdağ-Dündar O; Sarikaya M; Ertan R
J Enzyme Inhib Med Chem; 2008 Jun; 23(3):297-301. PubMed ID: 18569331
[TBL] [Abstract][Full Text] [Related]
7. Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca.
Abdel Motaal A; El-Askary H; Crockett S; Kunert O; Sakr B; Shaker S; Grigore A; Albulescu R; Bauer R
Phytomedicine; 2015 Aug; 22(9):829-36. PubMed ID: 26220630
[TBL] [Abstract][Full Text] [Related]
8. Phenolic compounds: The inhibition effect on polyol pathway enzymes.
Aslan HE; Beydemir Ş
Chem Biol Interact; 2017 Mar; 266():47-55. PubMed ID: 28153595
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic potential: In vitro inhibition effects of bromophenol and diarylmethanones derivatives on metabolic enzymes.
Demir Y; Taslimi P; Ozaslan MS; Oztaskin N; Çetinkaya Y; Gulçin İ; Beydemir Ş; Goksu S
Arch Pharm (Weinheim); 2018 Dec; 351(12):e1800263. PubMed ID: 30478943
[TBL] [Abstract][Full Text] [Related]
10. Some sulfonamides as aldose reductase inhibitors: therapeutic approach in diabetes.
Demir Y; Köksal Z
Arch Physiol Biochem; 2022 Aug; 128(4):979-984. PubMed ID: 32202954
[TBL] [Abstract][Full Text] [Related]
11. Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia.
Taslimi P; Aslan HE; Demir Y; Oztaskin N; Maraş A; Gulçin İ; Beydemir S; Goksu S
Int J Biol Macromol; 2018 Nov; 119():857-863. PubMed ID: 30077669
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of capsaicin inhibition of aldose reductase activity.
Alim Z; Kilinc N; Sengul B; Beydemir S
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28217947
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
14. Inhibition behaviours of some phenolic acids on rat kidney aldose reductase enzyme: an in vitro study.
Alim Z; Kilinç N; Şengül B; Beydemir Ş
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):277-284. PubMed ID: 28111996
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol.
Sampath C; Sang S; Ahmedna M
Biomed Pharmacother; 2016 Dec; 84():502-513. PubMed ID: 27685794
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and molecular docking studies of kaempferol and its prenylated derivatives as aldose reductase inhibitors.
Jung HA; Moon HE; Oh SH; Kim BW; Sohn HS; Choi JS
Chem Biol Interact; 2012 May; 197(2-3):110-8. PubMed ID: 22543015
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of aldose reductase from jerboa (Jaculus orientalis) and evaluation of its inhibitory activity by Euphorbia regis-jubae (Webb & Berth) extracts.
Hmimid F; Lahlou FA; Guenaou I; Nait Irahal I; Errami A; Fahde S; Bourhim N
Comp Biochem Physiol C Toxicol Pharmacol; 2021 Jun; 244():109001. PubMed ID: 33610817
[TBL] [Abstract][Full Text] [Related]
18. Structural bases for the inhibition of aldose reductase by phenolic compounds.
Rastelli G; Antolini L; Benvenuti S; Costantino L
Bioorg Med Chem; 2000 May; 8(5):1151-8. PubMed ID: 10882025
[TBL] [Abstract][Full Text] [Related]
19. Highly selective aldose reductase inhibitors. II. Optimization of the aryl part of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
Kotani T; Ishii A; Nagaki Y; Toyomaki Y; Yago H; Suehiro S; Okukado N; Okamoto K
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):297-304. PubMed ID: 9118444
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of ursolic acid derivatives on recombinant human aldose reductase.
Lee EH; Popov SA; Lee JY; Shpatov AV; Kukina TP; Kang SW; Pan CH; Um BH; Jung SH
Bioorg Khim; 2011; 37(5):637-44. PubMed ID: 22332359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
